Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
10,781,082
-
Total 13F shares
-
1,400,629
-
Share change
-
+53,913
-
Total reported value
-
$15,656,000
-
Price per share
-
$11.18
-
Number of holders
-
24
-
Value change
-
+$604,001
-
Number of buys
-
15
-
Number of sells
-
5
Institutional Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q3 2021
As of 30 Sep 2021 Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) had 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,400,629 shares of stock of the company.
Largest 10 holders included Corriente Advisors, LLC, VANGUARD GROUP INC, GWM Advisors LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Redmond Asset Management, LLC, WOLFF WIESE MAGANA LLC, Bank of New York Mellon Corp, RAYMOND JAMES & ASSOCIATES, and STATE STREET CORP.
This table shows 24 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.